TNX-102 SL Tablet clinical trials

A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants

This study looks at a new way to give a drug for fibromyalgia, called TNX-102 SL. It compares how the drug affects younger and older adults, focusing on safety and how much of the drug gets into the bloodstream.